康龙化成（03759）今日盘中大涨8.58%，截至午后交易，股价报23.44港元。该股今日表现强劲，引发市场广泛关注。
消息面上，美国投行富瑞发布研报，将康龙化成H股的目标价由22港元上调至28港元。富瑞表示，预计中国实验室服务业务将从下半年开始复苏，主要得益于中国生物科技公司的出海授权热潮。这一利好消息提振了投资者信心，推动康龙化成股价大幅上涨。
值得注意的是，康龙化成作为中国领先的药物研发外包公司，其H股今年以来表现亮眼，累计涨幅已达59.7%，大幅跑赢同期恒生指数28.8%的涨幅。此次股价强势上涨再次凸显了市场对公司未来发展前景的看好，也反映出投资者对中国生物科技行业整体复苏的乐观预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.